Growth Metrics

Whitehawk Therapeutics (WHWK) Profit After Tax (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.70%
Dec 31, 2025 -31.27%
Sep 30, 2025 66.27%
Jun 30, 2025 -172.06%
Mar 31, 2025 499.19%
Dec 31, 2024 -45.79%
Sep 30, 2024 13.97%
Jun 30, 2024 20.26%
Mar 31, 2024 -12.44%
Dec 31, 2023 0.21%
Sep 30, 2023 9.30%
Jun 30, 2023 -18.05%
Mar 31, 2023 -9.42%
Dec 31, 2022 4.05%
Sep 30, 2022 20.63%
Jun 30, 2022 -31.84%
Mar 31, 2022 13.34%
Dec 31, 2021 81.64%
Sep 30, 2021 -5,569.79%
Jun 30, 2021 71.95%
Mar 31, 2021 -168.47%
Dec 31, 2020 376.56%
Sep 30, 2020 45.25%
Jun 30, 2020 -58.90%
Mar 31, 2020 25.24%
Dec 31, 2019 4.34%
Sep 30, 2019 18.22%
Jun 30, 2019 33.08%
Mar 31, 2019 0.30%
Dec 31, 2018 -173.83%
Sep 30, 2018 292.61%
Jun 30, 2018 19.33%
Mar 31, 2018 -19.09%
Dec 31, 2017 -34.10%
Sep 30, 2017 15.77%
Jun 30, 2017 -10.50%
Mar 31, 2017 -42.01%
Dec 31, 2016 27.99%
Sep 30, 2016 -11.41%
Jun 30, 2016 -4.54%
Mar 31, 2016 -35,352.15%
Dec 31, 2015 -81.44%
Sep 30, 2015 10.33%
Jun 30, 2015 -25.06%
Mar 31, 2015 50.10%
Dec 31, 2014 -81.29%
Sep 30, 2014 7.54%
Jun 30, 2014 -20.57%
Mar 31, 2014 40.86%
Dec 31, 2013 -58.82%
Sep 30, 2013 9.04%
Jun 30, 2013 -11.31%
Mar 31, 2013 37.25%
Dec 31, 2012 -60.02%
Sep 30, 2012 4.20%
Jun 30, 2012 -17.55%
Mar 31, 2012 39.98%
Dec 31, 2011 -40.98%
Sep 30, 2011 6.26%
Jun 30, 2011 -31.16%
Mar 31, 2011 33.46%
Dec 31, 2010 -62.49%